Company intelligence / Profile preview
Chongqing Ximeien Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Chongqing Ximeien Pharmaceutical is a China-based biopharmaceutical company specializing in the research, development, and commercialization of high-end generic drugs and innovative biologics. The company maintains a strong focus on ophthalmology and oncology, with a pipeline featuring several biosimilar candidates targeting vascular endothelial growth factor (VEGF). Its lead programs include biosimilars for ranibizumab and bevacizumab, aimed at treating retinal diseases and various cancers. Ximeien operates integrated R&D and manufacturing facilities in Chongqing to support its goal of providing affordable, high-quality therapeutic solutions. The company is recognized as a key high-tech enterprise within the Chongqing region, contributing to the local biotechnology ecosystem.
- Therapeutic areas
- OncologyOphthalmology
- Modalities
- Monoclonal antibodyBiologicMonoclonal antibody fragmentRecombinant fusion proteinSmall molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Chongqing Ximeien Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chongqing Ximeien Pharmaceutical.